Keros Therapeutics (KROS) Stock Chart & Stock Price History $58.04 -1.60 (-2.68%) (As of 10/31/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Keros Therapeutics Stock Price Performance5 Day Performance-3.88%1 Month Performance+0.57%3 Month Performance+16.43%6 Month Performance+3.56%Year-To-Date Performance+46.88%1 Year Performance+104.63% Receive KROS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… KROS Stock Chart for Thursday, October, 31, 2024 KROS Chart by TradingView Keros Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/30/2024$60.14$59.64-0.83%$60.92$59.08266,405 shs$2.24 billion10/29/2024$60.73$60.14-0.97%$60.72$58.99251,099 shs$2.26 billion10/28/2024$60.76$60.73-0.05%$62.68$60.73302,359 shs$2.28 billion10/25/2024$59.56$60.76+2.01%$61.87$59.94258,241 shs$2.28 billion10/24/2024$57.99$59.56+2.71%$59.87$58.33366,465 shs$2.15 billion10/23/2024$59.33$57.99-2.26%$60.25$57.95189,334 shs$2.09 billion Get the Latest News and Ratings for KROS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/22/2024$60.30$59.33-1.61%$60.56$58.99137,583 shs$2.14 billion10/21/2024$61.25$60.30-1.55%$61.22$59.44262,353 shs$2.18 billion10/18/2024$61.09$61.25+0.26%$61.38$60.01340,419 shs$2.21 billion10/17/2024$62.18$61.09-1.75%$62.22$60.58292,562 shs$2.20 billion10/16/2024$60.39$62.18+2.96%$62.52$59.60584,100 shs$2.24 billion10/15/2024$60.50$60.39-0.18%$61.40$59.61396,235 shs$2.18 billion10/14/2024$59.78$60.50+1.20%$61.52$58.71339,420 shs$2.18 billion10/11/2024$57.79$59.78+3.44%$59.88$56.95219,469 shs$2.24 billion10/10/2024$57.97$57.79-0.31%$58.05$56.79266,897 shs$2.09 billion10/09/2024$59.67$57.97-2.85%$59.67$57.87145,883 shs$2.09 billion10/08/2024$60.12$59.67-0.75%$60.97$59.56166,230 shs$2.15 billion10/07/2024$60.90$60.12-1.28%$61.55$58.66219,898 shs$2.17 billion10/04/2024$59.90$60.90+1.67%$61.33$59.50264,408 shs$2.20 billion10/03/2024$61.31$59.90-2.30%$61.09$59.40238,795 shs$2.16 billion10/02/2024$59.79$61.31+2.54%$61.68$58.69457,231 shs$2.21 billion10/01/2024$58.07$59.79+2.96%$59.92$57.25465,877 shs$2.16 billion09/30/2024$56.45$58.07+2.87%$58.40$55.53343,969 shs$2.10 billion09/27/2024$56.88$56.45-0.76%$58.19$55.93283,463 shs$2.12 billion09/26/2024$56.45$56.88+0.76%$58.90$56.34313,862 shs$2.13 billion09/25/2024$55.59$56.45+1.55%$57.49$55.06338,353 shs$2.12 billion09/24/2024$54.54$55.59+1.93%$55.79$53.65303,057 shs$2.01 billion09/23/2024$55.80$54.54-2.26%$58.15$54.11680,958 shs$1.97 billion09/20/2024$57.32$55.80-2.65%$57.77$55.79846,975 shs$2.01 billion09/19/2024$55.71$57.32+2.89%$58.28$56.30393,952 shs$2.07 billion09/18/2024$55.04$55.71+1.22%$57.08$54.44229,813 shs$2.01 billion09/17/2024$55.62$55.04-1.04%$55.68$54.60464,867 shs$1.99 billion09/16/2024$56.98$55.62-2.39%$57.77$55.21280,255 shs$2.01 billion09/13/2024$56.40$56.98+1.03%$58.36$55.89356,642 shs$2.06 billion09/12/2024$54.75$56.40+3.01%$56.48$54.07355,040 shs$2.04 billion09/11/2024$54.69$54.75+0.11%$55.20$53.60289,765 shs$1.98 billion09/10/2024$53.88$54.69+1.50%$55.25$53.45271,244 shs$1.97 billion09/09/2024$52.51$53.88+2.61%$55.25$52.54344,624 shs$1.94 billion09/06/2024$53.68$52.51-2.18%$54.82$51.81402,858 shs$1.89 billion09/05/2024$52.93$53.68+1.42%$55.01$51.73470,097 shs$1.94 billionThe real reason Elon is fully endorsing Trump (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows,09/04/2024$47.79$52.93+10.76%$54.61$47.70772,711 shs$1.99 billion09/03/2024$45.35$47.79+5.38%$50.74$45.48379,350 shs$1.79 billion09/02/2024$45.35$45.35$46.65$44.93197,100 shs$1.70 billion08/30/2024$45.31$45.35+0.09%$46.65$44.93197,172 shs$1.64 billion08/29/2024$45.06$45.31+0.55%$46.24$44.8593,828 shs$1.63 billion08/28/2024$45.37$45.06-0.68%$46.04$44.5979,913 shs$1.63 billion08/27/2024$45.41$45.37-0.09%$45.62$44.62105,247 shs$1.64 billion08/26/2024$45.51$45.41-0.22%$46.48$45.15175,076 shs$1.64 billion08/23/2024$44.74$45.51+1.72%$45.84$44.45580,878 shs$1.64 billion08/22/2024$46.94$44.74-4.69%$47.05$44.66393,052 shs$1.61 billion08/21/2024$47.34$46.94-0.84%$48.64$46.23302,863 shs$1.69 billion08/20/2024$47.34$47.34$47.99$46.24158,554 shs$1.71 billion08/19/2024$45.54$47.34+3.95%$47.64$45.53250,874 shs$1.71 billion08/16/2024$46.04$45.54-1.09%$46.27$45.00192,348 shs$1.64 billion08/15/2024$43.37$46.04+6.16%$46.72$44.31324,289 shs$1.66 billion08/14/2024$44.62$43.37-2.80%$44.78$42.92424,570 shs$1.56 billion08/13/2024$44.84$44.62-0.49%$45.73$44.00538,738 shs$1.61 billion08/12/2024$45.38$44.84-1.19%$46.42$44.38122,104 shs$1.62 billion08/09/2024$44.41$45.38+2.18%$47.00$44.61155,989 shs$1.64 billion08/08/2024$45.40$44.41-2.18%$45.10$42.83270,301 shs$1.60 billion08/07/2024$48.76$45.40-6.89%$49.29$45.15222,644 shs$1.64 billion08/06/2024$47.21$48.76+3.28%$49.81$46.66204,550 shs$1.76 billion08/05/2024$49.15$47.21-3.95%$48.74$44.95335,489 shs$1.70 billion08/02/2024$50.36$49.15-2.40%$49.31$47.62272,964 shs$1.77 billion08/01/2024$50.16$50.36+0.40%$51.56$48.95343,652 shs$1.82 billion07/31/2024$51.37$50.16-2.36%$51.99$50.04211,961 shs$1.81 billion07/30/2024$52.03$51.37-1.27%$52.60$51.28207,598 shs$1.85 billion Related Companies Scholar Rock Stock Price Chart Y-mAbs Therapeutics Stock Price Chart Amarin Stock Price Chart FibroGen Stock Price Chart Madrigal Pharmaceuticals Stock Price Chart Roivant Sciences Stock Price Chart Revolution Medicines Stock Price Chart Legend Biotech Stock Price Chart Intra-Cellular Therapies Stock Price Chart Viking Therapeutics Stock Price Chart Receive KROS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KROS) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keros Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Keros Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.